Howland Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Buy	4,534 +300	+7%	+$90.5K	0.05%	143
2026 Q1	$1.4M	Sell	4,234 -9	-0.2%	-$3.06K	0.06%	135
2025 Q4	$1.69M	Hold	4,243	–	–	0.06%	122
2025 Q3	$1.93M	Buy	4,243 +243	+6%	+$99K	0.07%	120
2025 Q2	$1.3M	Hold	4,000	–	–	0.05%	139
2025 Q1	$1.08M	Hold	4,000	–	–	0.05%	146
2024 Q4	$941K	Hold	4,000	–	–	0.04%	150
2024 Q3	$1.1M	Hold	4,000	–	–	0.05%	144
2024 Q2	$972K	Hold	4,000	–	–	0.05%	140
2024 Q1	$598K	Hold	4,000	–	–	0.03%	173
2023 Q4	$766K	Buy	+4,000	New	+$681K	0.04%	150
2023 Q3	–	Sell	-4,000	Closed	-$760K	–	246
2023 Q2	$760K	Hold	4,000	–	–	0.04%	149
2023 Q1	$801K	Hold	4,000	–	–	0.05%	142
2022 Q4	$951K	Hold	4,000	–	–	0.06%	130
2022 Q3	$801K	Buy	+4,000	New	+$763K	0.05%	132